Overall, lifetime prevalence
of any use of smokeless tobacco ranged from 6% (Baumert et al.
It found that lifetime prevalence
of PTSD among Vietnam veterans was 31% for men and 27% for women.
The lifetime prevalence
of NO use in the total sample was 15.
372) and New Zealand have found lifetime prevalence
rates for common mental disorders that are about half as large as those in the new investigation.
At least one parent from each family was interviewed by a trained researcher using the Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version (SCID) (17) and/or the SCID Screen Patient Questionnaire Extended Computer Program (hereafter SCID computer screen or computer screen) to determine the lifetime prevalence
rates of psychiatric disorders.
of diagnosed diseases was as follows: cataract, 8.
The researchers found a high lifetime prevalence
of nonsuicidal self-harm.
Dr Corrigan said: "In terms of age groups, lifetime prevalence
for any illegal drugs was highest among those aged 25 to 34 years (34 per cent), followed by those aged 15 to 24 years (28 per cent) and those aged 35 to 44 years (27 per cent).
The lifetime prevalence
of pervitin use in Slovakia's population increased from 0.
Although bipolar disorder traditionally has been thought to have a lifetime prevalence
of only about 1% in the general population, (7,8) clinical and epidemiologic studies are leading to a substantial upward revision of this estimate.
1996) found that the lifetime prevalence
of bipolar disorder in a sample of children and adolescents with ADHD doubled over a 4-year period, increasing from 11 percent to 23 percent.
Furthermore, MTF lifetime prevalence
figures indicate that the percentage of students who have tried inhalants remains at high levels.
The survey examined anxiety, mood, impulse control, and substance abuse disorders and quantified lifetime prevalence
, age of onset, delay in treatment seeking, prevalence and severity in a given year, treatment and quality of care in a given year, and barriers to treatment.
Then, we present a series of analyses that first, treat inhalant use as a dependent variable and compare the risk factors associated with lifetime prevalence
with the risk factors for other psychoactive substances, and second, treat inhalant use as an independent variable predicting other problem behaviors.
rates in various countries for bipolar I disorder, bipolar II disorder, bipolar spectrum disorder and schizophrenia were identified from population-based epidemiological studies that used similar methods.